Cases & Deals

MerLion Pharmaceuticals places shares

Clients MerLion Pharmaceuticals Pte. Ltd.

Jones Day counseled MerLion Pharmaceuticals Pte. Ltd., a pharmaceutical company engaged in the discovery and development of drug candidates for bacterial and fungal resistance levels, in its issuance of Convertible Preferred Stock in a private placement to Aravis Venture, Bio*One Capital Pte. Ltd., Nomura Research and Advisory, Aurelia Private Equity, Brandenburg Capital, Bioveda Capital, Novartis Venture Fund, Mitsubishi Corporation, and 3i Group Investment LP.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.